These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 39285270

  • 1. Access and barriers to safer supply prescribing during a toxic drug emergency: a mixed methods study of implementation in British Columbia, Canada.
    Urbanoski KA, van Roode T, Selfridge M, Hogan KC, Fraser J, Lock K, McGreevy PB, Burmeister C, Barker B, Slaunwhite A, Nosyk B, Pauly B.
    Subst Abuse Treat Prev Policy; 2024 Sep 16; 19(1):44. PubMed ID: 39285270
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada.
    Foreman-Mackey A, Pauly B, Ivsins A, Urbanoski K, Mansoor M, Bardwell G.
    Subst Abuse Treat Prev Policy; 2022 Oct 08; 17(1):66. PubMed ID: 36209227
    [Abstract] [Full Text] [Related]

  • 4. Factors associated with obtaining prescribed safer supply among people accessing harm reduction services: findings from a cross-sectional survey.
    Palis H, Haywood B, McDougall J, Xavier CG, Desai R, Tobias S, Burgess H, Ferguson M, Liu L, Kinniburgh B, Slaunwhite AK, Crabtree A, Buxton JA.
    Harm Reduct J; 2024 Jan 06; 21(1):5. PubMed ID: 38184576
    [Abstract] [Full Text] [Related]

  • 5. A qualitative evaluation of a fentanyl patch safer supply program in Vancouver, Canada.
    Norton A, Ivsins A, Holliday E, Sutherland C, Kerr T, Kennedy MC.
    Int J Drug Policy; 2024 Sep 06; 131():104547. PubMed ID: 39159532
    [Abstract] [Full Text] [Related]

  • 6. British Columbia's Safer Opioid Supply Policy and Opioid Outcomes.
    Nguyen HV, Mital S, Bugden S, McGinty EE.
    JAMA Intern Med; 2024 Mar 01; 184(3):256-264. PubMed ID: 38227344
    [Abstract] [Full Text] [Related]

  • 7. Influence of physician networks on the implementation of pharmaceutical alternatives to a toxic drug supply in British Columbia.
    Kurz M, Guerra-Alejos BC, Min JE, Barker B, Pauly B, Urbanoski K, Nosyk B.
    Implement Sci; 2024 Jan 06; 19(1):3. PubMed ID: 38184548
    [Abstract] [Full Text] [Related]

  • 8. Community partner perspectives on the implementation of a novel safer supply program in Canada: a qualitative study of the MySafe Project.
    Mansoor M, Foreman-Mackey A, Ivsins A, Bardwell G.
    Harm Reduct J; 2023 Apr 28; 20(1):61. PubMed ID: 37118799
    [Abstract] [Full Text] [Related]

  • 9. Access to tablet injectable opioid agonist therapy in rural and smaller urban settings in British Columbia, Canada: a qualitative study.
    Bardwell G, Bowles JM, Mansoor M, Werb D, Kerr T.
    Subst Abuse Treat Prev Policy; 2023 Mar 03; 18(1):14. PubMed ID: 36869358
    [Abstract] [Full Text] [Related]

  • 10. Implementation of Safe Supply Alternatives During Intersecting COVID-19 and Overdose Health Emergencies in British Columbia, Canada, 2021.
    McNeil R, Fleming T, Mayer S, Barker A, Mansoor M, Betsos A, Austin T, Parusel S, Ivsins A, Boyd J.
    Am J Public Health; 2022 Apr 03; 112(S2):S151-S158. PubMed ID: 35262376
    [Abstract] [Full Text] [Related]

  • 11. Preferred pharmaceutical-grade opioids to reduce the use of unregulated opioids: A cross-sectional analysis among people who use unregulated opioids in Vancouver, Canada.
    Speed KA, Choi J, Felicella G, Sedgemore KO, Mok WY, Milloy MJ, DeBeck K, Kerr T, Hayashi K.
    Int J Drug Policy; 2024 Oct 03; 132():104564. PubMed ID: 39236550
    [Abstract] [Full Text] [Related]

  • 12. Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: A qualitative analysis.
    Karamouzian M, Rafat B, Kolla G, Urbanoski K, Atkinson K, Bardwell G, Bonn M, Touesnard N, Henderson N, Bowles J, Boyd J, Brunelle C, Eeuwes J, Fikowski J, Gomes T, Guta A, Hyshka E, Ivsins A, Kennedy MC, Laurence G, Martignetti L, Nafeh F, Salters K, Tu D, Strike C, Pauly B, Werb D.
    Int J Drug Policy; 2023 Oct 03; 120():104157. PubMed ID: 37574645
    [Abstract] [Full Text] [Related]

  • 13. Overdose Prevention and Housing: a Qualitative Study Examining Drug Use, Overdose Risk, and Access to Safer Supply in Permanent Supportive Housing in Vancouver, Canada.
    Ivsins A, MacKinnon L, Bowles JM, Slaunwhite A, Bardwell G.
    J Urban Health; 2022 Oct 03; 99(5):855-864. PubMed ID: 36044156
    [Abstract] [Full Text] [Related]

  • 14. Prescribed safer supply during dual public health emergencies: a qualitative study examining service providers perspectives on early implementation.
    McCall J, Hobbs H, Ranger C, Cameron F, Stuart H, Nelken J, Majalahti J, Urbanoski K, Kolla G, LeMaistre J, Toombs K, Herriot R, Pauly B.
    Subst Abuse Treat Prev Policy; 2024 Mar 05; 19(1):19. PubMed ID: 38444035
    [Abstract] [Full Text] [Related]

  • 15. 'I'm on the coast and I'm on methadone': A qualitative study examining access to opioid agonist treatment in rural and coastal British Columbia.
    Hodgson K, Bowles JM, Mansoor M, Rooke E, Bardwell G.
    Can J Rural Med; 2024 Jul 01; 29(3):117-124. PubMed ID: 39155634
    [Abstract] [Full Text] [Related]

  • 16. Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies.
    Giang K, Charlesworth R, Thulien M, Mulholland A, Barker B, Brar R, Pauly B, Fast D.
    Int J Drug Policy; 2023 May 01; 115():104023. PubMed ID: 37059025
    [Abstract] [Full Text] [Related]

  • 17. Factors associated with 60-day adherence to "safer supply" opioids prescribed under British Columbia's interim clinical guidance for health care providers to support people who use drugs during COVID-19 and the ongoing overdose emergency.
    Selfridge M, Card K, Kandler T, Flanagan E, Lerhe E, Heaslip A, Nguyen A, Moher M, Pauly B, Urbanoski K, Fraser C.
    Int J Drug Policy; 2022 Jul 01; 105():103709. PubMed ID: 35525052
    [Abstract] [Full Text] [Related]

  • 18. "Am I gonna get in trouble for acknowledging my will to be safe?": Identifying the experiences of young sexual minority men and substance use in the context of an opioid overdose crisis.
    Goodyear T, Mniszak C, Jenkins E, Fast D, Knight R.
    Harm Reduct J; 2020 Mar 30; 17(1):23. PubMed ID: 32228646
    [Abstract] [Full Text] [Related]

  • 19. Peer-led safer supply and opioid agonist treatment medication distribution: a case study from rural British Columbia.
    Scow M, McDougall J, Slaunwhite A, Palis H.
    Harm Reduct J; 2023 Oct 25; 20(1):156. PubMed ID: 37875927
    [Abstract] [Full Text] [Related]

  • 20. "COVID just kind of opened a can of whoop-ass": The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada.
    Glegg S, McCrae K, Kolla G, Touesnard N, Turnbull J, Brothers TD, Brar R, Sutherland C, Le Foll B, Sereda A, Goyer MÈ, Rai N, Bernstein S, Fairbairn N.
    Int J Drug Policy; 2022 Aug 25; 106():103742. PubMed ID: 35679695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.